D-0874-2026 Class II Ongoing

Recalled by Aurolab Trust — Madurai

FDA drug recall D-0874-2026 was initiated by Aurolab Trust on Sep 17, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 25,220 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 7, 2026
Initiation Date
Sep 17, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
25,220 bottles

Product description

FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

VA

Code information

Batch# 6B093FI, Exp. 04/01/28; Batch# 6F511F1, Exp. 05/15/28

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0874-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0874-2026. Report a data issue: hello@regdatalab.com.